Platform
Features
Pricing
ImmunoKey
Contact
No bio yet
Gray Kueberuwa
CEO
John Bridgeman
Chief Scientific Officer
Nicola Price
Non-executive Director And Cofounder
This person is not in any teams
This person is not in any offices
ImmunoKey is pioneering next-generation CAR T-cell therapies to overcome the challenges of successfully treating solid tumours. https://www.immunokey.co.uk/
Industries
Employees
Links
DASA
Prepared
jalebi.io
SEASALT.AI
Reach Giant